nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—SLC22A6—Furosemide—dilated cardiomyopathy	0.336	0.54	CbGbCtD
Diflunisal—ALB—Furosemide—dilated cardiomyopathy	0.286	0.46	CbGbCtD
Diflunisal—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00812	0.0244	CcSEcCtD
Diflunisal—Cholestasis—Furosemide—dilated cardiomyopathy	0.00722	0.0217	CcSEcCtD
Diflunisal—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00716	0.0215	CcSEcCtD
Diflunisal—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00659	0.0198	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00659	0.0198	CcSEcCtD
Diflunisal—Gastritis—Spironolactone—dilated cardiomyopathy	0.00648	0.0195	CcSEcCtD
Diflunisal—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00576	0.0173	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00559	0.0168	CcSEcCtD
Diflunisal—Renal failure—Spironolactone—dilated cardiomyopathy	0.00554	0.0167	CcSEcCtD
Diflunisal—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00526	0.0158	CcSEcCtD
Diflunisal—TTR—Non-integrin membrane-ECM interactions—LAMA4—dilated cardiomyopathy	0.00497	0.112	CbGpPWpGaD
Diflunisal—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00494	0.111	CbGpPWpGaD
Diflunisal—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00491	0.0147	CcSEcCtD
Diflunisal—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00479	0.0144	CcSEcCtD
Diflunisal—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00468	0.0141	CcSEcCtD
Diflunisal—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00462	0.0139	CcSEcCtD
Diflunisal—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00453	0.0136	CcSEcCtD
Diflunisal—Deafness—Furosemide—dilated cardiomyopathy	0.00445	0.0134	CcSEcCtD
Diflunisal—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00441	0.0133	CcSEcCtD
Diflunisal—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00424	0.0127	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00422	0.0127	CcSEcCtD
Diflunisal—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00368	0.0111	CcSEcCtD
Diflunisal—Confusional state—Spironolactone—dilated cardiomyopathy	0.00363	0.0109	CcSEcCtD
Diflunisal—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0036	0.0108	CcSEcCtD
Diflunisal—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00359	0.0108	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00359	0.0108	CcSEcCtD
Diflunisal—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00352	0.0106	CcSEcCtD
Diflunisal—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.0034	0.0102	CcSEcCtD
Diflunisal—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00331	0.00994	CcSEcCtD
Diflunisal—TTR—Non-integrin membrane-ECM interactions—DMD—dilated cardiomyopathy	0.00329	0.074	CbGpPWpGaD
Diflunisal—Somnolence—Spironolactone—dilated cardiomyopathy	0.0032	0.00961	CcSEcCtD
Diflunisal—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00314	0.00944	CcSEcCtD
Diflunisal—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00314	0.00943	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00304	0.00914	CcSEcCtD
Diflunisal—Renal failure—Furosemide—dilated cardiomyopathy	0.00302	0.00906	CcSEcCtD
Diflunisal—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00296	0.00891	CcSEcCtD
Diflunisal—Sweating—Furosemide—dilated cardiomyopathy	0.00294	0.00884	CcSEcCtD
Diflunisal—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00286	0.0086	CcSEcCtD
Diflunisal—Urticaria—Spironolactone—dilated cardiomyopathy	0.00286	0.00859	CcSEcCtD
Diflunisal—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00284	0.00854	CcSEcCtD
Diflunisal—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00269	0.00808	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00269	0.00808	CcSEcCtD
Diflunisal—Visual impairment—Furosemide—dilated cardiomyopathy	0.00265	0.00798	CcSEcCtD
Diflunisal—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00265	0.00796	CcSEcCtD
Diflunisal—Gastritis—Lisinopril—dilated cardiomyopathy	0.00264	0.00794	CcSEcCtD
Diflunisal—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0026	0.00783	CcSEcCtD
Diflunisal—Tinnitus—Furosemide—dilated cardiomyopathy	0.00257	0.00772	CcSEcCtD
Diflunisal—Pruritus—Spironolactone—dilated cardiomyopathy	0.00254	0.00765	CcSEcCtD
Diflunisal—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00254	0.00763	CcSEcCtD
Diflunisal—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00246	0.0074	CcSEcCtD
Diflunisal—Dysuria—Lisinopril—dilated cardiomyopathy	0.00241	0.00725	CcSEcCtD
Diflunisal—Dizziness—Spironolactone—dilated cardiomyopathy	0.00238	0.00715	CcSEcCtD
Diflunisal—Flatulence—Furosemide—dilated cardiomyopathy	0.00236	0.0071	CcSEcCtD
Diflunisal—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00236	0.00708	CcSEcCtD
Diflunisal—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00231	0.00693	CcSEcCtD
Diflunisal—Vomiting—Spironolactone—dilated cardiomyopathy	0.00229	0.00687	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00228	0.00686	CcSEcCtD
Diflunisal—Rash—Spironolactone—dilated cardiomyopathy	0.00227	0.00681	CcSEcCtD
Diflunisal—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00227	0.00681	CcSEcCtD
Diflunisal—Renal failure—Lisinopril—dilated cardiomyopathy	0.00226	0.0068	CcSEcCtD
Diflunisal—Vision blurred—Furosemide—dilated cardiomyopathy	0.00226	0.00679	CcSEcCtD
Diflunisal—Headache—Spironolactone—dilated cardiomyopathy	0.00225	0.00677	CcSEcCtD
Diflunisal—Jaundice—Lisinopril—dilated cardiomyopathy	0.00224	0.00674	CcSEcCtD
Diflunisal—Sweating—Lisinopril—dilated cardiomyopathy	0.00221	0.00663	CcSEcCtD
Diflunisal—Haematuria—Lisinopril—dilated cardiomyopathy	0.00219	0.0066	CcSEcCtD
Diflunisal—Vertigo—Furosemide—dilated cardiomyopathy	0.00215	0.00647	CcSEcCtD
Diflunisal—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00215	0.00646	CcSEcCtD
Diflunisal—Nausea—Spironolactone—dilated cardiomyopathy	0.00214	0.00642	CcSEcCtD
Diflunisal—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00207	0.00621	CcSEcCtD
Diflunisal—Hallucination—Lisinopril—dilated cardiomyopathy	0.00206	0.00618	CcSEcCtD
Diflunisal—Confusional state—Furosemide—dilated cardiomyopathy	0.00197	0.00593	CcSEcCtD
Diflunisal—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.00196	0.0441	CbGpPWpGaD
Diflunisal—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00196	0.00588	CcSEcCtD
Diflunisal—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00195	0.00587	CcSEcCtD
Diflunisal—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00193	0.00579	CcSEcCtD
Diflunisal—Shock—Furosemide—dilated cardiomyopathy	0.00193	0.00579	CcSEcCtD
Diflunisal—Flushing—Lisinopril—dilated cardiomyopathy	0.00192	0.00576	CcSEcCtD
Diflunisal—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00192	0.00576	CcSEcCtD
Diflunisal—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00189	0.00568	CcSEcCtD
Diflunisal—Anorexia—Furosemide—dilated cardiomyopathy	0.00187	0.00561	CcSEcCtD
Diflunisal—Flatulence—Lisinopril—dilated cardiomyopathy	0.00177	0.00533	CcSEcCtD
Diflunisal—Tension—Lisinopril—dilated cardiomyopathy	0.00177	0.0053	CcSEcCtD
Diflunisal—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00176	0.00528	CcSEcCtD
Diflunisal—Nervousness—Lisinopril—dilated cardiomyopathy	0.00175	0.00525	CcSEcCtD
Diflunisal—Somnolence—Furosemide—dilated cardiomyopathy	0.00174	0.00523	CcSEcCtD
Diflunisal—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00173	0.0052	CcSEcCtD
Diflunisal—Decreased appetite—Furosemide—dilated cardiomyopathy	0.0017	0.00511	CcSEcCtD
Diflunisal—Vision blurred—Lisinopril—dilated cardiomyopathy	0.0017	0.00509	CcSEcCtD
Diflunisal—Fatigue—Furosemide—dilated cardiomyopathy	0.00169	0.00507	CcSEcCtD
Diflunisal—Constipation—Furosemide—dilated cardiomyopathy	0.00167	0.00503	CcSEcCtD
Diflunisal—Angioedema—Lisinopril—dilated cardiomyopathy	0.00164	0.00494	CcSEcCtD
Diflunisal—Vertigo—Lisinopril—dilated cardiomyopathy	0.00162	0.00486	CcSEcCtD
Diflunisal—Syncope—Lisinopril—dilated cardiomyopathy	0.00161	0.00485	CcSEcCtD
Diflunisal—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00161	0.00485	CcSEcCtD
Diflunisal—TTR—Non-integrin membrane-ECM interactions—ITGB1—dilated cardiomyopathy	0.00161	0.0361	CbGpPWpGaD
Diflunisal—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.0016	0.00481	CcSEcCtD
Diflunisal—Palpitations—Lisinopril—dilated cardiomyopathy	0.00159	0.00478	CcSEcCtD
Diflunisal—TTR—Amyloids—NPPA—dilated cardiomyopathy	0.00159	0.0356	CbGpPWpGaD
Diflunisal—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00158	0.00475	CcSEcCtD
Diflunisal—Urticaria—Furosemide—dilated cardiomyopathy	0.00155	0.00467	CcSEcCtD
Diflunisal—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00155	0.00465	CcSEcCtD
Diflunisal—Chest pain—Lisinopril—dilated cardiomyopathy	0.00153	0.0046	CcSEcCtD
Diflunisal—Confusional state—Lisinopril—dilated cardiomyopathy	0.00148	0.00445	CcSEcCtD
Diflunisal—Oedema—Lisinopril—dilated cardiomyopathy	0.00147	0.00441	CcSEcCtD
Diflunisal—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00147	0.00441	CcSEcCtD
Diflunisal—Shock—Lisinopril—dilated cardiomyopathy	0.00144	0.00434	CcSEcCtD
Diflunisal—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00144	0.00433	CcSEcCtD
Diflunisal—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00144	0.00432	CcSEcCtD
Diflunisal—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00142	0.00427	CcSEcCtD
Diflunisal—Asthenia—Furosemide—dilated cardiomyopathy	0.0014	0.00422	CcSEcCtD
Diflunisal—Anorexia—Lisinopril—dilated cardiomyopathy	0.0014	0.00421	CcSEcCtD
Diflunisal—Pruritus—Furosemide—dilated cardiomyopathy	0.00138	0.00416	CcSEcCtD
Diflunisal—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00134	0.00402	CcSEcCtD
Diflunisal—Insomnia—Lisinopril—dilated cardiomyopathy	0.00133	0.00399	CcSEcCtD
Diflunisal—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00132	0.00396	CcSEcCtD
Diflunisal—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00131	0.00393	CcSEcCtD
Diflunisal—Somnolence—Lisinopril—dilated cardiomyopathy	0.00131	0.00392	CcSEcCtD
Diflunisal—Dizziness—Furosemide—dilated cardiomyopathy	0.00129	0.00389	CcSEcCtD
Diflunisal—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00129	0.00388	CcSEcCtD
Diflunisal—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00128	0.00384	CcSEcCtD
Diflunisal—Fatigue—Lisinopril—dilated cardiomyopathy	0.00127	0.0038	CcSEcCtD
Diflunisal—Constipation—Lisinopril—dilated cardiomyopathy	0.00126	0.00377	CcSEcCtD
Diflunisal—Vomiting—Furosemide—dilated cardiomyopathy	0.00124	0.00374	CcSEcCtD
Diflunisal—Rash—Furosemide—dilated cardiomyopathy	0.00123	0.00371	CcSEcCtD
Diflunisal—Dermatitis—Furosemide—dilated cardiomyopathy	0.00123	0.0037	CcSEcCtD
Diflunisal—Headache—Furosemide—dilated cardiomyopathy	0.00123	0.00368	CcSEcCtD
Diflunisal—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00121	0.00364	CcSEcCtD
Diflunisal—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0012	0.00361	CcSEcCtD
Diflunisal—Urticaria—Lisinopril—dilated cardiomyopathy	0.00117	0.00351	CcSEcCtD
Diflunisal—Nausea—Furosemide—dilated cardiomyopathy	0.00116	0.00349	CcSEcCtD
Diflunisal—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00116	0.00349	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00114	0.0257	CbGpPWpGaD
Diflunisal—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00108	0.00325	CcSEcCtD
Diflunisal—Asthenia—Lisinopril—dilated cardiomyopathy	0.00105	0.00317	CcSEcCtD
Diflunisal—Pruritus—Lisinopril—dilated cardiomyopathy	0.00104	0.00312	CcSEcCtD
Diflunisal—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.001	0.00302	CcSEcCtD
Diflunisal—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00099	0.0222	CbGpPWpGaD
Diflunisal—Dizziness—Lisinopril—dilated cardiomyopathy	0.000971	0.00292	CcSEcCtD
Diflunisal—Vomiting—Lisinopril—dilated cardiomyopathy	0.000934	0.00281	CcSEcCtD
Diflunisal—Rash—Lisinopril—dilated cardiomyopathy	0.000926	0.00278	CcSEcCtD
Diflunisal—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000925	0.00278	CcSEcCtD
Diflunisal—Headache—Lisinopril—dilated cardiomyopathy	0.00092	0.00276	CcSEcCtD
Diflunisal—Nausea—Lisinopril—dilated cardiomyopathy	0.000872	0.00262	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.000768	0.0172	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.000757	0.017	CbGpPWpGaD
Diflunisal—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.000717	0.0161	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000617	0.0139	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000588	0.0132	CbGpPWpGaD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.00054	0.0121	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000535	0.012	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.00051	0.0114	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000474	0.0106	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000455	0.0102	CbGpPWpGaD
Diflunisal—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000454	0.0102	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00045	0.0101	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—TAZ—dilated cardiomyopathy	0.000446	0.01	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000433	0.00973	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—SDHA—dilated cardiomyopathy	0.000403	0.00905	CbGpPWpGaD
Diflunisal—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000391	0.00878	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000375	0.00842	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00037	0.00831	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00037	0.0083	CbGpPWpGaD
Diflunisal—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00036	0.00809	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.00035	0.00785	CbGpPWpGaD
Diflunisal—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000332	0.00747	CbGpPWpGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00031	0.00697	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000302	0.00679	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000301	0.00675	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.000294	0.00659	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000289	0.00648	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000281	0.0063	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000274	0.00615	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000264	0.00593	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000245	0.00549	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00024	0.00539	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000237	0.00533	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000235	0.00528	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000234	0.00526	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000234	0.00525	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000233	0.00524	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000229	0.00514	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000229	0.00513	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000229	0.00513	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000223	0.005	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000218	0.0049	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000212	0.00477	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000209	0.0047	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000202	0.00453	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000195	0.00437	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000194	0.00436	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000186	0.00417	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000185	0.00416	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00018	0.00405	CbGpPWpGaD
Diflunisal—TTR—Disease—NPPA—dilated cardiomyopathy	0.000175	0.00394	CbGpPWpGaD
Diflunisal—TTR—Disease—PSEN2—dilated cardiomyopathy	0.00017	0.00382	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000169	0.00381	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000166	0.00373	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000161	0.00361	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000153	0.00344	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000143	0.00321	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.000141	0.00317	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000125	0.00281	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000122	0.00275	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000122	0.00274	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00012	0.00269	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000119	0.00267	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000119	0.00267	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000119	0.00267	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000117	0.00264	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000115	0.00259	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000115	0.00258	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000114	0.00256	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000113	0.00254	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00011	0.00248	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GPX1—dilated cardiomyopathy	0.000109	0.00246	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CD36—dilated cardiomyopathy	0.000107	0.00239	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000106	0.00239	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000106	0.00237	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000106	0.00237	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.000104	0.00234	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	9.92e-05	0.00223	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.82e-05	0.00221	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—AGT—dilated cardiomyopathy	9.6e-05	0.00216	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.51e-05	0.00214	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	9.33e-05	0.0021	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	9.27e-05	0.00208	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	9.1e-05	0.00204	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	8.64e-05	0.00194	CbGpPWpGaD
Diflunisal—TTR—Disease—RAC1—dilated cardiomyopathy	8.55e-05	0.00192	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	8.44e-05	0.00189	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	8.14e-05	0.00183	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.13e-05	0.00183	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	8.03e-05	0.0018	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.71e-05	0.00173	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	7.56e-05	0.0017	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TAZ—dilated cardiomyopathy	7.55e-05	0.0017	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	7.5e-05	0.00168	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	7.36e-05	0.00165	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	7.2e-05	0.00162	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SDHA—dilated cardiomyopathy	6.82e-05	0.00153	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.62e-05	0.00149	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.48e-05	0.00146	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.31e-05	0.00142	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RAC1—dilated cardiomyopathy	5.99e-05	0.00134	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AGT—dilated cardiomyopathy	5.72e-05	0.00128	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.68e-05	0.00128	CbGpPWpGaD
Diflunisal—TTR—Disease—RAF1—dilated cardiomyopathy	5.67e-05	0.00127	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	5.4e-05	0.00121	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	5.22e-05	0.00117	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NPPA—dilated cardiomyopathy	5.16e-05	0.00116	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.15e-05	0.00116	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	5.14e-05	0.00116	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.01e-05	0.00113	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PSEN2—dilated cardiomyopathy	4.99e-05	0.00112	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.9e-05	0.0011	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.63e-05	0.00104	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.51e-05	0.00101	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CD36—dilated cardiomyopathy	4.45e-05	0.001	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—RAC1—dilated cardiomyopathy	4.2e-05	0.000943	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.16e-05	0.000935	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.05e-05	0.000911	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RAF1—dilated cardiomyopathy	3.97e-05	0.000891	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—dilated cardiomyopathy	3.89e-05	0.000873	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.65e-05	0.00082	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	2.89e-05	0.000648	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CD36—dilated cardiomyopathy	2.81e-05	0.000631	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—RAF1—dilated cardiomyopathy	2.78e-05	0.000625	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGFR—dilated cardiomyopathy	2.72e-05	0.000611	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—AGT—dilated cardiomyopathy	2.53e-05	0.000569	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RAC1—dilated cardiomyopathy	2.51e-05	0.000564	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.41e-05	0.000541	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	2.29e-05	0.000515	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CD36—dilated cardiomyopathy	2.23e-05	0.000501	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AGT—dilated cardiomyopathy	2.01e-05	0.000451	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GPX1—dilated cardiomyopathy	1.85e-05	0.000416	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CD36—dilated cardiomyopathy	1.81e-05	0.000406	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RAF1—dilated cardiomyopathy	1.67e-05	0.000374	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AGT—dilated cardiomyopathy	1.63e-05	0.000365	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—dilated cardiomyopathy	1.14e-05	0.000256	CbGpPWpGaD
